Press Release From The Cancer Institute of New Jersey
May 21, 2007
Contact: Michele Fisher
Foundation for NCI-Designated Cancer Center Selects New Officers
Metuchen Resident Re-elected Chair of CINJ Foundation Board of Trustees
New Brunswick — The Cancer Institute of New Jersey Foundation (CINJF) has selected its slate of officers for Fiscal Year 2008, which begins July 1. CINJF, a non-profit organization, raises funds to support New Jersey’s only National Cancer Institute – designated Comprehensive Cancer Center, an elite distinction held by only 38 other cancer centers in the country.
Metuchen resident Leslie Logan Taylor, Managing Partner, Matrix Development Group, was selected again to serve as chairperson. “It is through the commitment of this body that we will be able to continue to support the extraordinary cancer research, treatment, education and prevention programs for the people of New Jersey,” said Taylor. “We are fortunate that we are able to draw from our collective experience to promote CINJ’s fight against cancer.”
Former CINJ Director William N. Hait, M.D., Ph.D., of Princeton will serve as President of the Board. Hait is the Senior Vice President and Head Worldwide Hematology/Oncology Research and Development at Johnson & Johnson. He also is the current President of the American Association for Cancer Research.
Cranbury resident James M. Golubieski, who is the President of New Jersey Health Foundation, Inc. and the Foundation of University of Medicine and Dentistry of New Jersey, was selected as Vice Chairperson and Secretary of the CINJF Board of Trustees.
Thomas A. Bracken of Skillman will serve as Treasurer. He is the former President and Chief Executive Officer of Sun National Bank.
“Thanks to the dedication and commitment of the CINJ Foundation Board of Trustees, our physicians and scientists are able to advance research in areas such as cancer prevention, the development of vaccines and the discovery of more effective, less toxic treatments, said Joseph R. Bertino, M.D., Interim Director, CINJ and University Professor of Medicine and Pharmacology, UMDNJ-Robert Wood Johnson Medical School. “With continued support, CINJ is able to provide the best cancer care for all New Jerseyans, right in their own communities.”
Still in its infancy, CINJF has raised $10-million dollars since it was formed nearly two years ago. It raises funds through corporation and foundation support, gifts from individuals, special events and planned giving. To support New Jersey’s only NCI –designated Comprehensive Cancer Center call 732 235-8614 or visit http://www.cinj.org/Foundation/index.htm.
Board of Trustees of The Cancer Institute of New Jersey Foundation
William Wood Allen [Princeton]
Chief Executive Officer, Wood Allen Capital Management LLC
Peter S. Amenta, M.D., Ph.D. [Princeton Junction]
Interim Dean, UMDNJ-Robert Wood Johnson Medical School
Margery Baker-Riker [New York City]
Vice President, CBS News Productions
Subha V. Barry [Princeton]
Managing Director, Head of Multicultural Careers, Merrill Lynch and Company, Inc.
Thomas A. Bracken [Skillman]
Former President and Chief Executive Officer, Sun National Bank
Robert E. Campbell [North Brunswick]
Vice Chairman (Retired), Johnson and Johnson
Jeffrey N. Edwards [Basking Ridge]
Senior Vice President and Chief Financial Officer, Merrill Lynch and Company, Inc.
James M. Golubieski [Cranbury]
President, New Jersey Health Foundation, Inc. and Foundation of University of Medicine and Dentistry of New Jersey
Audrey Gould [Princeton]
Senior Vice President, Wachovia Securities
William N. Hait, M.D., Ph.D. [Princeton]
Senior Vice President and Head Worldwide Hematology/Oncology Research and Development, Johnson & Johnson
Duncan L. MacMillan [Princeton]
Co-Founder, Bloomberg, LP (Retired)
Paul Mignon [Skillman]
President and Chief Operating Officer, Ventive Health, Inc.
Stephen J. Riker [New York City]
Vice Chairman, Colliers ABR, Inc.
Michelle Morton [San Diego, CA]
Chief Executive Officer, Pacific American Securities, LLC
Leslie Logan Taylor – Chair [Metuchen]
Managing Partner, Matrix Development Group
Bruce C. Vladeck, Ph.D. [New York City]
Interim President, University of Medicine and Dentistry of New Jersey
John R. Whitman [Oldwick]
Managing Partner, Sycamore Management Corp.
Mark A. Wolters [Toms River]
President and Chief Executive Officer, Grand Bank
Arshad R. Zakaria [New Vernon]
President and Chief Executive Officer, New Vernon Capital LLC
About the Cancer Institute of New Jersey Foundation
The Cancer Institute of New Jersey Foundation is a 501 (c)(3) charitable organization that exists to raise funds to support the programs and purpose of The Cancer Institute of New Jersey (CINJ). To support CINJ, please call The Cancer Institute of New Jersey Foundation at 1-888-333-CINJ.
About The Cancer Institute of New Jersey
The Cancer Institute of New Jersey is the state’s first and only National Cancer Institute-designated Comprehensive Cancer Center, and is dedicated to improving the prevention, detection, treatment and care of patients with cancer. CINJ’s physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice quite literally bringing research to life. The Cancer Institute of New Jersey is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
The Cancer Institute of New Jersey Network is comprised of hospitals throughout the state and provides a mechanism to rapidly disseminate important discoveries into the community. Partner Hospitals: Robert Wood Johnson University Hospital, Atlantic Health (Morristown Memorial Hospital, Overlook Hospital). Affiliate Hospitals: Bayshore Community Hospital, CentraState Healthcare System, Cooper University Hospital,* Jersey Shore University Medical Center, JFK Medical Center, Mountainside Hospital , Raritan Bay Medical Center, Robert Wood Johnson University Hospital at Hamilton (CINJ-Hamilton), Saint Peter’s University Hospital, Somerset Medical Center, Southern Ocean County Hospital, The University Hospital/UMDNJ-New Jersey Medical School*, and University Medical Center at Princeton.